In an effort to increase accuracy and speed, improve detection limits and reduce uncertainties in internal dosimetry, laboratories have developed improved or new internal monitoring techniques in both in vivo measurements and bioassay analyses. Most of these techniques have not yet entered routine monitoring programmes. This paper intends to summarise these new techniques, show their potential improvements compared to the currently employed monitoring routines and discuss the main aspects of the EC-funded IDEA project, which aims at a comprehensive assessment of these techniques and the enhancements necessary to bring them to broader acceptance in the routine monitoring community.